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The longing for longevity without decrepitude is 
ancient. Homer tells us that to live out his days with 
Penelope, Odysseus rejected immortality. Later restored 
to family and kingdom, the gods’ further favour 
included being able to look forward to an unenfeebled 
old age. So how goes our longing now? Around the 
world, although life expectancy is increasing for most 
people,1 a wholly healthy old age is elusive. In The Lancet, 
Carol Jagger and colleagues2 make clear that whether 
we reckon the ancient longing to be realised depends 
on how we measure health, and on which perspective 
we have. The authors compared the results from two 
rounds of the Cognitive Function and Ageing Study, 
done in England in 1991 and 2011. Health expectancy 
was measured in three ways: self-perceived health, 
life without disability, and time free from cognitive 
impairment.
In 2011, on a background of increasing life 
expectancy, men spent 3·8 more years (95% CI 
3·5–4·1), and women spent 3·1 more years (2·7–3·4), 
in good or better self-perceived health than in 1991. 
Similarly, fewer people rated their health as fair or 
poor in 2011 than in 1991, although this eﬀ ect was 
not signiﬁ cant after adjustment for region, education, 
and deprivation. In contrast to a Swedish report3 
of cohorts studied 30 years apart, the prevalence of 
disability increased. However, the pattern gives some 
cause for hope: men spent 1·3 more years (1·1–1·6) 
with mild disability, compared with 0·5 years (0·3–0·8) 
with moderate–severe disability; the corresponding 
ﬁ gures for women were 2·5 years (2·2–2·8) with mild 
disability and 0·6 years (0·3–0·9) with moderate–
severe disability. Although more time was spent with 
disability, moderate–severe disability decreased, so that 
the increase—and most of the additional time lived—
was spent in a mildly disabled state. The least equivocal 
change was that less time was spent by women with 
cognitive impairment (0·7 years [0·2–1·3]), and more 
time spent without cognitive impairment (4·4 years 
[4·3–4·5]), in 2011 than in 1991. Achievement of longer 
life and reduced impairment is an important step 
towards the Homeric ideal.
Especially for cognitive health, what future progress 
can be made is debated. The decline in cognitive 
impairment was not insubstantial (odds ratio [OR] 
0·53 [95% CI 0·49–0·56]). Most of this decrease 
was accounted for by a decline in severe cognitive 
impairment (OR 0·49, [0·43–0·56]). This decrease is 
much larger than that returned so far on the massive 
investments in research on dementia biomarkers 
and hoped-for disease-modifying therapies. Those 
investments gamble that any positive results from 
proof-of-concept trials in younger (ie, from their 40s) 
and often otherwise well patients, especially from 
high-risk samples, will be relevant to older adults 
with many health deﬁ cits, who are the most common 
patients with dementia.4 Equally, whether improving 
overall health—lessening health deﬁ cits and their 
eﬀ ects—would further result in reduced cognitive 
impairment is unknown.5,6
Jagger and colleagues2 suggest that the observed 
increase in mild disability might result from speciﬁ c 
problems, notably obesity and musculoskeletal 
disease. Here, caution must be urged. Although 
understanding which illnesses contribute to disability 
is important, disability rates are potently related to 
age. As a result, the extent of overall, age-related 
deﬁ cit accumulation might be as important to 
disability rates as which illnesses people have.7 Health 
deﬁ cits are not just diseases, but can range from 
even minor laboratory abnormalities8 to lower than 
average enjoyment of life.9 For this reason, a broadly 
construed approach to improving health might pay 
current and future dividends. So too might a broadly 
What can we expect of health in old age?
Published Online
December 8, 2015
http://dx.doi.org/10.1016/
S0140-6736(15)01022-3
See Articles page 779
M
CT
/C
on
tr
ib
ut
or
Comment
www.thelancet.com   Vol 387   February 20, 2016 731
construed health measure. At present, many single 
items vie as overall health measures—in addition 
to the three health measures assayed by Jagger and 
colleagues,2 or laboratory test abnormalities or life 
enjoyment, are several other measures, including grip 
strength, drawing a clock, and the time it takes to get 
out of a chair and walk.9 Under the rubric of measuring 
frailty, dozens of measures now combine such items, 
although which should be combined and how many 
should be counted are disputed.7 Even if the “problems 
of old age come as a package”,10 quantiﬁ cation of the 
package in which those problems come is a challenge 
for ageing research.
Which view we take aﬀ ects our understanding of 
whether progress is being made towards improved 
health expectancy. For example, whether women are 
more prone than men to disability, or whether disability 
is more lethal in men than in women, are two accounts 
of the same phenomenon.11 That disparities in the 
extent of health deﬁ cits between men and women vary 
mostly by whether self-reported or test data are used 
suggests that sex and gender perspectives run deeply 
enough to aﬀ ect mortality risk.12
Perspective also matters. For individuals, an estimate 
of health expectancy provides a sense of their own 
chances. Policy makers must consider how health 
expectancy as, for example, disability prevalence, plays 
out against a background of an increasing number 
of older adults.1 Obviously, a modestly decreasing 
numerator will not trump a relentlessly increasing 
denominator. The numbers will out, with important 
eﬀ ects for ageing societies, especially for pensions and 
health care in which progress is needed. An English 
audit of intermediate care opens boldly: “The modern 
general hospital is complex, expensive and has proved 
harmful to many [older] people, and so simpler, cheaper 
and safer care alternatives have been sought.”13 The 
data from the Cognitive Function and Ageing Studies 
do not support complacency in public policy. Jagger 
and colleagues2 have documented important gains in 
health expectancies. Even so, it seems that living the 
unenfeebled old age promised to Odysseus will still 
somehow need special favour.
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